File: bbe20bvw4_pub_nl.pdfTrial reference: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of PF-06939926 for the Treatment of Duchenne Muscular DystrophyDoc type: Information for the public